| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 7 |
| 1 | ADALIMUMAB-ADAZ | 4 |
| 2 | IBRUTINIB | 4 |
| 3 | INFLIXIMAB | 4 |
| 4 | RITUXIMAB | 4 |
| 5 | ADALIMUMAB-AATY | 3 |
| 6 | ADALIMUMAB-FKJP | 3 |
| 7 | CLOPIDOGREL | 3 |
| 8 | DENOSUMAB | 3 |
| 9 | ETANERCEPT | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 1 | TEBENTAFUSP | 1 | 0.0017 |
| 2 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 3 | MOSUNETUZUMAB | 1 | 0.0009 |
| 4 | ZANUBRUTINIB | 2 | 0.0004 |
| 5 | HYPROMELLOSE | 1 | 0.0004 |
| 6 | GLOFITAMAB | 1 | 0.0004 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 2 | 0.0002 |
| 9 | CILOSTAZOL | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Nitrate Vasodilator [EPC] | 2 | 0.0000 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 2 | 0.0000 |
| 9 | RANK Ligand Inhibitor [EPC] | 3 | 0.0000 |